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Sunlnlary 
Several studies have suggested that there is a direct interaction between the T cell receptor (TCR) 
and  the  major  histocompatibility  complex  (MHC)  molecule  during  T  cell  recognition  of 
superantigen.  To further investigate this possibility, we have analyzed T  cell recognition  of a 
bacterial superantigen, Staphylococcal enterotoxin B (SEB), presented by a series of mutant murine 
I-E  k molecules in which residues of either the c~ or ~  chain predicted to interact with the TCR 
have been substituted.  Individual T  cell hybridomas gave distinct patterns of responsiveness to 
SEB presented by the I-EB  k mutants that could not be attributed to differences in the binding 
of SEB to the mutants. This effect appeared to be dependent on the TCR-c~ chain because some 
of these hybridomas  expressed identical  TCR  transgenic  3  chains.  In contrast,  none of the 
hybridomas gave distinct  patterns  of responsiveness to SEB presented by the I-Eot  k mutants. 
Taken together, these observations support the idea that there is a functional interaction between 
the ot chain of the TCR and the 3  chain of the MHC class II molecule. The data also support 
the idea that  this interaction  might  enhance  superantigen  recognition  in  some cases. 
S 
uperantigens are characterized by their ability to stimu- 
late high frequencies of T cells expressing particular V/~ 
elements. A current model for superantigen activation of T 
cells  suggests that  the superantigen  interacts directly with 
the class  II molecule and the TCR V3 element,  resulting 
in cross-linking of the two molecules (1). In addition, there 
is a growing body of evidence to suggest that there is a direct 
interaction between the MHC class II molecule and the TCR 
during  superantigen  engagement  that  can influence super- 
antigen-mediated  activation of some T  ceils  (2). First,  de- 
ments of the TCR-ot chain have been shown to affect the 
ability of T cells to respond to superantigens (3-6). Second, 
it has been shown that MHC polymorphisms can also affect 
the ability of T  cell lines and hybridomas to be stimulated 
by viral and bacterial superantigens  (4, 7, 8). These effects 
were not due to the inability of the superantigens  to bind 
to the class II molecules but rather were the result of preferen- 
tial recognition of superantigen-MHC haplotype complexes 
by the T  cells.  Third,  mutational and structural analysis  of 
the bacterial superantigen Staphylococcal enterotoxin B (SEB) 
suggests that the TCR and MHC molecules are brought into 
dose proximity during  superantigen  engagement  (9-11). 
In the current study, we investigated the hypothesis that 
TCR-MHC interactions modulate superantigen reactivity by 
testing the ability of wild-type and mutant  I-E  k molecules 
to present  the bacterial  superantigen,  SEB,  to T  cells. 
Materials  and Methods 
I-E~-expressing Cell Lines.  The Chinese hamster ovary (CHO) 
transfectants expressing I-E  ~ wild-type and mutant molecules have 
been described previously (12). The cells were stained with the anti- 
I-E  k mAb Y17 (13) to determine surface MHC expression. All of 
the cell lines used in this study expressed similar levels of the trans- 
fected I-E  k molecules (within a twofold range). A CHO cell trans- 
fectant that did not express detectable surface MHC class II mole- 
cules was used as a negative control in all experiments (data not 
shown). 
T  Cell Hybridomas.  T  cell hybridomas  577  (V38.2+),  590 
(V38.1§  and 610 (V~8.2 +) have been described previously (4). 
Hybridomas  1230, 1345, and  1357 were  derived from VB8.1 + 
transgenic mice on the CBA/CaJ background by fusion of acti- 
vated CD4 § T cells with the c~-3- variant of the T cell thymoma 
BW5147 as described previously (5). 
Hybridoma Reactivity to SEB,  Hybridoma reactivity was deter- 
mined by a standard  Ib2 assay as described previously (7,  14). 
Briefly, 105 hybridomas were cultured with 105 CHO transfectants 
in 250 gl cultures in complete medium. Supematants were removed 
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IL-2-dependent HT-2 cells. 
SEB dose-response curves were performed for each hybridoma 
and the concentration of SEB required to stimulate IL-2 secretion 
half-maximally was  determined.  To normalize  the results, the 
response of the hybridomas to SEB presented by the mutant I-E  k 
molecules was compared with the response with wild-type I-E  k- 
presenting cells, which was given an arbitrary value of 1 (termed 
relative responses). Each dose-response curve was  performed a 
minimum of three times and the relative responses averaged, and 
expressed as the mean __ SE. Commercial SEB was purchased from 
Sigma Chemical Co. (St. Louis, MO) and the recombinant SEB 
plasmid was a kind gift of Dr. John Kappler (National Jewish Center 
for Immunology,  Denver, CO). Recombinant  SEB was prepared 
as described by Kappler et al. (9). 
In some experiments, the CHO transfectants were fixed with 
1% paraformaldehyde for 30 min at room temperature. The cells 
were washed three times with complete medium and used in a stan- 
dard IL-2 assay as described above. 
SEB Biotinylation and Binding Assay.  SEB binding  to  I-E  k 
CHO transfectants was measured using biotinylated SEB. Biotiny- 
lation  of SEB was  carried  out  using  sulfosuccinimidyl-6-(bio- 
tinamido) (NHS-LC-biotin) (Pierce, Rockford, IL) and a modifica- 
tion of the manufacturer's protocol. Briefly, SEB was dissolved in 
50 mM sodium bicarbonate buffer (pH 8.5). NHS-LC-biotin was 
dissolved in ddH20 and mixed with SEB at a molar ratio of 160:1 
biotin/SEB and incubated at room temperature for 30 min. Free 
biotin was removed and the buffer changed to lx PBS by repeated 
centrifugations using Centricon-10 concentrators (Amicon Corp., 
Beverly, MA).  These conditions resulted in the incorporation  of 
four biotin molecules per SEB molecule as determined using avidin 
(Pierce) and Immunopure 2-(4'-hydroxyazobenzene) benzoic acid 
(HABA) (Pierce) following the instructions prescribed by the man- 
ufacturer. 
Binding studies were performed by incubating biotinylated SEB 
(at concentrations ranging from 0.23 to 15 #M) with CHO trans- 
fectants (4  x  105 cells/well) for 2 h on ice. Samples were washed 
three times with staining buffer (lx PBS,  0.1% sodium azide, 1% 
FCS), PE coupled to strepavidin (TAGO Inc., Burlingame, CA) 
was added and samples incubated for 20 min on ice. The cells were 
washed twice with staining buffer and analyzed on a FACScan  | 
(Becton Dickinson & Co., Mountain View, CA). Fluorescence in- 
tensity was calculated by subtracting  the fluorescence signal ob- 
tained by staining a class II negative CHO transfectant with bi- 
otinylated SEB from the fluorescence  signal obtained from the I-E  k 
positive cell lines. The background fluorescence signals of the class 
II negative CHO transfectant ranged between a mean fluorescence 
intensity  of 3.0-4.0. 
Results and Discussion 
Previous studies have suggested that there is a direct inter- 
action between the TCR and MHC molecules during the 
recognition of both retroviral and bacterial  superantigens 
(reviewed in 2). One prediction of this model is that muta- 
tion of residues on the top face of the class II molecule which 
are accessible to the TCR would influence superantigen rec- 
ognition. To test this hypothesis we used 12 I-Ek mutants 
expressed in CHO cells, previously characterized by Ehrich 
et al. (12) (Table 1). Each of the mutations introduced a single 
amino acid substitution in a residue predicted to be involved 
in  TCR-MHC  interactions during  conventional peptide- 
Table  1.  Class II-expressing CHO Transfectants Used in This 
Study* 
I-E  k ot chain mutation  I-E  k/3 chain mutation 
ot57 S ~N  1364 Q"*R 
ot61 Q~R  /369 E ~K 
ot65 A-*V  /373 A-*V 
ot68 A'-*V  /377 T'-*Q 
ot72 A ~V  /381 H~Y 
ot79 E ~  K  /384 E ~  K 
" CHO transfectants  have  been described  previously  (12). Each cell line 
expresses I-E  k molecules that have single amino acid substitutions in 
either the oe or the/3 chain. Amino acid changes are shown by the single 
letter code. 
MHC recognition (15).  The substituted amino acids were 
of similar hydrophobicity to the wild-type residue but either 
had an opposite charge or a bulkier side chain.  Therefore, 
secondary and tertiary structures of the MHC molecule were 
maintained while promoting maximum disruption of potential 
TCR-MHC contact points. Consistent with this prediction, 
the wild-type and mutant I-Ek-expressing CHO cells were 
shown to be indistinguishable in their ability to bind pep- 
tides and anti-I-E antibodies (12).  In addition, all the mu- 
tants, except 369 and 381, were found to bind the bacterial 
superantigen SEA normally (12). 
To determine the effects of I-E  k mutations on bacterial  su- 
perantigen SEB recognition, we first tested the transfectants 
for their ability to bind SEB. Direct binding studies revealed 
that the I-Eot k mutants bound biotinylated SEB comparable 
with wild-type I-E  k molecules (Fig.  1 A). There was a 5-10- 
fold range of SEB binding to the I-E/3  k mutants (Fig.  1 B). 
Interestingly, the mutation at position 81 in the I-E  k/3 chain 
did not affect SEB binding.  This residue has been defined 
as critical for SEA binding to both the HLA DR1 (16,  17) 
and MHC I-E  k molecule (12). Thus, these data are consis- 
tent with the idea that SEB and SEA bind to different regions 
of MHC class II (reviewed in  18). 
The I-E  k mutants were used to present SEB to a panel of 
26 V/38 + T  cell hybridomas (4 V/38.1 +,  13/3 chain trans- 
genic  [TG]  V/38.1 +,  and  9  V/38.2 +  hybridomas).  Dose- 
response curves were generated for each hybridoma to SEB 
presented by each of the I-E  k mutants and wild-type I-E  k. 
Figs. 2 and 3 show the relative responses of six representative 
hybridomas (590-V/38.1 +;  1230,  1345,  1357-TG V/38.1 +; 
577, 610-V/38.2+).  In each case, the data are presented as the 
relative shift in the dose response curve of each mutant com- 
pared with  the wild-type I-E  k control. 
Five important observations can be drawn from these data. 
First, all six of the hybridomas shown expressed distinct pat- 
terns of reactivity to the I-E  k/3 chain mutants. For example, 
hybridomas 590 and 1230 gave a reciprocal pattern of respon- 
siveness to SEB presented by mutants/369,/377, and/384 (Fig. 
2, A  and C).  Hybridoma 1230 preferentially responded to 
SEB presented by/369 and/384, whereas 590 preferentially 
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Figure  1.  SEB binding curves to wild-type 
and mutant  MHC class II molecules.  Bio- 
tinylated SEB was incubated with the CHO 
transfectants expressing I-E~ ot chain (.4) or 
/5 chain (B) mutants for 2 h on ice. PE-avidin 
was added to each sample and SEB binding 
was determined  by relative fluorescence in- 
tensity. Fluorescence intensity was calculated 
by subtracting  the background  fluorescence 
signal (obtained  by staining a class II nega- 
tive CHO transfectant with biotinylated SEB) 
from the fluorescence signal obtained  from 
the I-E  k positive  cell lines.  The data  rep- 
resents the average of three individual experi- 
ments. Cells were simultaneously stained for 
surface  I-E  L levels and  shown  to  express 
equivalent (within a twofold range) amounts 
of surface class 1I molecules. A CHO trans- 
fectant that lacked surface MHC class II ex- 
pression was used as a negative control (data 
not shown). 
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Figure 2.  Effect of I-E  k B chain mutations on recognition of the bac- 
terial superantigen  SEB by V~8 + T cell hybridomas.  T  cell hybridomas 
590 (V/38.1 +) (A); 1345 (TG V/~8.1 +) (/3); 1230 (TG V/38.1 +) (C); 1357 
(TG V/~8.1 §  (D); 577 (VB8.2 +) (E); and 610 (V38.2 +) (F) were tested 
for the ability to recognize SEB presented by CHO cells expressing 3 chain 
mutant I-E  k molecules. SEB dose-response curves were performed for each 
hybridoma by using various concentrations  of commercial or recombinant 
SEB. The concentration of SEB required  to stimulate  each hybrid  half- 
maximally ([SEB]I/2 ~,.)  was  determined based  upon  the maximum 
amount of II.-2 produced from each hybrid. Data are presented as the rela- 
tive response of the hybrids  to each mutant as compared  with the wild 
type,  which is arbitrarily  set at a value of one.  Each bar represents  the 
mean +- SE of three to seven experiments.  WT refers to the CHO trans- 
fectant  expressing wild-type I-E  k molecule. 
responded to/377. Although/577 bound SEB more weakly 
than wild-type I-E  k (Fig. 1 B), /577 can present SEB well 
to four out of six hybridomas (Fig. 2). Several  other distinct 
patterns of reactivity were observed among the hybridomas 
suggesting  that fine specificity for SEB was a characteristic 
of the TCR and not SEB binding. These patterns of reac- 
tivity were extremely  reproducible as shown by minimal vari- 
ations in these experiments. Moreover, identical patterns were 
obtained  using CHO  transfectants  that had been fixed in 
paraformaldehyde and by using either recombinant SEB or 
commercial preparations of SEB (data not shown). Thus the 
distinct patterns of SEB recognition by the hybridomas cannot 
readily be explained by processing of SEB into peptides, con- 
taminants within the commercial SEB preparation or differen- 
tial binding of SEB to the various I-E~  k mutants (see Fig. 
1 B). In addition,  the reciprocal patterns of SEB recognition 
rule out the possibility that the expression of different adhe- 
sion molecules on the hybridomas was responsible for their 
reactivity.  Therefore, these data strongly support the hypothesis 
that there is a direct TCR-MHC interaction during SEB rec- 
ognition, which can influence T  cell activation. 
Second, distinct patterns of SEB reactivity were observed 
between hybridomas  which expressed identical  transgenic 
TCR-/5 chains (hybridomas 1230, 1345, and 1357). For ex- 
ample, hybridoma 1230 responded well to SEB presented by 
369 but weakly to 377, whereas 1357 responded well to SEB 
presented by/577 but not to/569.  Therefore, these data sug- 
gest that residues on the a  chain of the TCR interact with 
residues on the/5 chain of the MHC class II molecule. This 
hypothesis is consistent with the findings of several groups 
(3-6) that the c~ chain of the TCR can have a strong influence 
on the recognition of both SEB and the viral superantigen, 
Mls-1, and is supported  by recent crystallographic analysis 
of SEB bound to the human Dtkl molecule (11). It is in- 
teresting  to note that the mutation of 369 consistently re- 
duced the response ofaU 17 V/58.1 hybridomas tested irrespec- 
tive of the TCR-ot chain (Fig. 2 and data not shown). This 
observation suggests that residue/569 of the MHC might 
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610  Figure  3.  Effect  of I-E  k (x chain mutations on 
recognition of the bacterial superantigen SEB by 
V138 + T cell hybridomas. T cell hybridomas  590 
(V/38.1 +) (.4); 1345 (TG V/~8.1  +) (B); 1230 (TG 
V/38.1 +) (C); 1357 (TG V/38.1 +) (D); 577 (VJ38.2  +) 
(E); and 610  (V/38.2  +)  (F)  were tested for the 
ability  to recognize  SEB presented  by CHO cells  ex- 
pressing ~ chain mutant I-E  k molecules.  The rela- 
tive responses of the hybridomas  were determined 
as described in Fig. 2. 
contact conserved residues of the TCR-~ chain framework 
region. We are currently analyzing TCR-ot chain usage in 
these TG hybridomas. 
Third, some of the hybridomas responded more strongly 
to SEB presented by mutant I-E  ~ molecules than presented 
by wild-type I-EL For example,  590 gave a 10-fold stronger 
response to SEB presented on/373 and 1377 compared with 
presentation by wild-type I-E  k.  Interestingly, these muta- 
tions at positions 1373 (A-~V) and/377 (T--~Q)  increase the 
size of the side chain groups. In mutagenesis studies of pro- 
tein-protein interactions it is not uncommon to find that an 
increase in side chain size (or a charge reversal) can enhance 
interactions. This observation is consistent with the findings 
that bulky side chains can enhance TCR-MHC-antigen rec- 
ognition (12). The increased responsiveness  seen with these 
mutations was not due to increased SEB binding (Fig.  1 B) 
and was not a characteristic of all hybridomas (for example, 
1345 responses were 10-fold weaker to SEB presented by these 
mutants compared with wild-type). 
Fourth, most of the V/38.2 + hybridomas responded simi- 
larly to all I-E  k mutants (610, Fig. 2 F, and data not shown). 
It is interesting to note that V/38.2 + T cells are thought to 
have a higher affinity for SEB than V/38.1 + T cells (7), con- 
sistent with the hypothesis that TCRs with a high affinity 
for superantigen are less influenced by TCR-MHC interac- 
tions (2). In support of this hypothesis, the VB8.2 + hybrid- 
omas studied here generally responded to nanomolar amounts 
of SEB, whereas the V/38.1 + hybridomas required micro- 
molar amounts of SEB (data not shown). However, we did 
identify one V/38.2 + hybridoma, 577 (Fig. 2 E), with a dis- 
tinct pattern of SEB recognition. This observation demon- 
strates that TCR-MHC interactions can also influence strongly 
SEB-reactive  hybridomas. 
Fifth, in contrast to the I-E  k/3 chain mutants, recogni- 
tion of the I-E  k c~ chain mutants did not reveal distinct pat- 
terns of fine specificity among the hybridomas (Fig. 3). Al- 
though  individual mutants  appeared  to  be  stronger  (for 
example, ot61) or weaker (for example, ot57, 65, 68, 72, 79) 
presenters  of SEB, all hybridomas gave essentially the same 
pattern of SEB recognition. These differences did not corre- 
late with binding of SEB. For example,  ot61 did not bind 
SEB better than the other mutants (Fig.  1 A). Therefore, 
the data obtained from analysis of these I-E  k ot chain muta- 
tions provides no evidence for interaction between the TCR 
and the MHC ot chain. This is consistent with the crystallo- 
graphic analysis of the HLA DR1/SEB complex which indi- 
cates that much of the MHC c~ chain is buried under the 
SEB molecule and is presumably not able to contact TCR 
(11). The observation that mutation of the I-E  k a  chain at 
position 61 considerably enhanced SEB reactivity is interesting 
in this regard. Labrecque et al. (8) have proposed that class 
II molecules may induce a conformational change on bound 
bacterial superantigens which is necessary for TCR recogni- 
tion (based upon the study by Gascoigne and Ames [19]). 
The generic effect  of I-E  k a  chain mutations, specifically 
a61, is consistent with an effect on the structural conforma- 
tion of bound SEB. 
Taken together, the data presented show that mutations 
within the I-E  k 13 chain but not the I-E  k ot chain, resulted 
in unique patterns of SEB recognition by V/38  + T  cells. 
These data are fully consistent with the hypothesis that residues 
within the MHC class II 13 chain contact the TCR and can 
1934  T Cell Recognition of a Bacterial Superantigen influence superantig~n-mediated T cell activation. Furthermore, 
a comparison of T  cell responses  between hybridomas ex- 
pressing transgenic fl chain TCRs suggests that the TCR-cx 
chain is involved in contacting the fl chain of the MHC. This 
hypothesis is consistent with the TCR-MHC orientation 
predicted by the recent crystallographic studies of DR1-SEB 
complexes  (11). 
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